ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MYL Mylan NV

15.855
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Mylan NV NASDAQ:MYL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 15.855 15.71 15.90 0 01:00:00

Mylan Schedules Second Quarter 2015 Financial Results Conference Call and Live Webcast

24/07/2015 8:28pm

PR Newswire (US)


Mylan NV (NASDAQ:MYL)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Mylan NV Charts.

HERTFORDSHIRE, England and PITTSBURGH, July 24, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, announced today that it will host a conference call and live webcast on Thursday, August 6, 2015, at 10 a.m. ET, to review the company's financial results for the second quarter ended June 30, 2015. Mylan will release its financial results on August 6, before the market opens.

The dial-in number to access the call is 800.514.4861 or 678.809.2405 for international callers. To access the live webcast, please log on to Mylan's website, mylan.com, at least 15 minutes before the event is scheduled to begin to register and download or install any necessary software. A replay of the webcast will be available at mylan.com/investors, for a limited time.

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. Our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mylan-schedules-second-quarter-2015-financial-results-conference-call-and-live-webcast-300118581.html

SOURCE Mylan N.V.

Copyright 2015 PR Newswire

1 Year Mylan NV Chart

1 Year Mylan NV Chart

1 Month Mylan NV Chart

1 Month Mylan NV Chart

Your Recent History

Delayed Upgrade Clock